Search clinical trials for: MA-GVHD-401

Total 5335 results

Incyte Corporation

Recruiting

Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease (THRIVE)

cGVHD

United States
IRCCS Policlinico S. Matteo

Completed

Comparison of Two Automated Mononuclear Collection Systems in Patients Undergoing Extracorporeal Photochemotherapy. A Cross-over Equivalence Study. (MNC_CMNC) (CMNC_MNC)

GvHD | Lung Graft Dysfunction

Italy
Hong Kong Baptist University

Completed

A Blended Intervention to Promote Physical Activity, Health and Work Productivity Among Office Employees

Physically Well But Worried

Hong Kong
Neurogene Inc.

Recruiting

A Novel, Regulated Gene Therapy (NGN-401) Study for Female Children With Rett Syndrome

Rett Syndrome

United States
Kyowa Kirin Co., Ltd.

Active, not recruiting

Study of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma (NHL)

Indolent B-cell Non-Hodgkin's Lymphoma

Japan
Kyowa Kirin Co., Ltd.

Active, not recruiting

Study of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma

Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma

Japan
Bridge Biotherapeutics, Inc.
KCRN Research, LLC

Completed

First-In-Human Study of BBT-401-1S Following Single and Multiple Ascending Doses in Healthy Volunteers

Ulcerative Colitis

United States
Shenzhen Geno-Immune Medical Institute

Unknown

Clonal Fetal Mesenchymal Stem Cells (cfMSCs) for the Control of Immune-related Disorders

Tissue Damage | Immune Related Disorder

China
Marker Therapeutics, Inc.

Active, not recruiting

Efficacy of MT-401 in Patients With AML Following Stem Cell Transplant (ARTEMIS)

Acute Myeloid Leukemia | Stem Cell Transplantation

United States
MEI Pharma, Inc.

Terminated

Zandelisib (ME-401) in Subjects With Follicular Lymphoma or Marginal Zone Lymphoma After Failure of Two or More Prior Therapies (TIDAL)

Marginal Zone Lymphoma | Non Hodgkin Lymphoma | Follicular Lymphoma (FL)

United States, Spain, Korea, Republic of, Belgium, Taiwan, Germany, France, Italy, Australia, Poland, New Zealand, United Kingdom, Austria, Switzerland
Shanghai Jiao Tong University School of Medicine

Completed

PT-CY With or Without Low-dose ATG for Lymphoid Malignancies Undergoing Allo-HSCT

GVHD, Acute

China
Forte Biosciences, Inc.

Terminated

Continued Safety Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis Previously Enrolled in the FB401-01 Study

Atopic Dermatitis

United States
Benitec BioPharma Ltd

Completed

A Study of BB-401 in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Head and Neck Squamous Cell Carcinoma

Australia, Russian Federation
Celgene Corporation

Terminated

Study to Determine the Optimal Biologic Dose of CC-401 in Subjects With High-Risk Myeloid Leukemia

Myeloid Leukemia

United States
Centre Hospitalier Universitaire de Besancon

Unknown

Multimarker Approach for Acute Dyspnea in Elderly Patients Admitted in the Emergency Department (READ-MA)

Acute Heart Failure | Acute Dyspnea

France
Stemline Therapeutics, Inc.

Completed

Tagraxofusp (SL-401) in Patients With CMML or MF

Myelofibrosis | Chronic Myelomonocytic Leukemia

United States, Canada
Stemline Therapeutics, Inc.

Terminated

SL-401 as Consolidation Therapy in Patients With Adverse Risk Acute Myeloid Leukemia in First Complete Remission

Acute Myeloid Leukemia

United States
Ariel University
Tel Aviv University

Unknown

The Effect of Transcranial Direct Current Stimulation of the Somatosensory Area on Upper Limb Motor Performance

Healthy

Israel
University of Messina

Recruiting

Investigating the Effects of Intensity of Transcranial Direct Current Stimulation on Subjective Appetite (tDCS)

Healthy

Italy
University of Michigan

Completed

Earned Income Tax Credit Access Study

The Study is Intended to Increase Take-up of EITC

United States
Mats Remberger
The Swedish Research Council

Recruiting

Decidua Stroma Cells for Steroid Resistent Acute Graft-versus-host Disease After Allo-HSCT (2017-00355)

GVHD, Acute

Sweden, Norway, Denmark
MaaT Pharma

Recruiting

Prospective Interventional Study Exploring the Microbiota Recolonization in SR-GvHD Patients Receiving MaaT013 (ORION)

Steroid Refractory GVHD | Intestinal GVHD

France
CSL Behring

Terminated

Exploratory Safety Study of ALD518 in Subjects With Steroid-refractory Acute Graft Versus Host Disease (GVHD) (ALD518-010)

Acute GvHD

United States
University of Michigan
National Institute on Aging (NIA)

Recruiting

Stimulation to Improve Memory (STIM)

Mild Cognitive Impairment | Dementia of Alzheimer Type

United States
California Pacific Medical Center Research Institute
National Institutes of Health (NIH); University of California, San Francisco; San Francisco General Hospital

Completed

Steady State Kinetics of l-Methamphetamine and Validation of Sensitivity of Dose Estimation

Nasal Congestion

United States
Fujian Medical University

Unknown

ATG-F VS ATG for the Prevention of GVHD

GVHD in the Setting of Haplo-HSCT

China
University Hospital, Montpellier

Completed

Criteria Associated With Patient Willingness to Participate in Biomedical Research (PROTOACCEPT)

Consulting in Pneumology Department, But Not for Oncology or Tobacology

France
DSM Nutritional Products, Inc.
Abbott Nutrition

Completed

Effects of Lutein on Learning and Memory in Chronically Stressed Subjects and in an Acute Stressful Situation (TSST - Trier Social Stress Test): A Randomized, Double-blind, Placebo-controlled Trial) (MemLearn)

Healthy But Chronically Stressed

Germany
Haemonetics Corporation

Terminated

RapidTEG MA Validation (R-TEG MA)

Coagulation | Platelet Function

United States
University of Iowa

Completed

Antegrade Versus Retrograde IV for Blood Draws

There is no Focus on Any Specific Condition

United States
University of Iowa

Completed

4 mA tDCS, Estrogen, and Leg Muscle Fatigability

Healthy

United States
Jacob Soumerai, MD
MEI Pharma, Inc.

Withdrawn

Zandelisib + Tazemetostat in R/R Follicular Lymphoma

Relapsed Follicular Lymphoma | Refractory Follicular Lymphoma

United States
Astellas Pharma Global Development, Inc.

Completed

A Study of ASP0367 in People With Kidneys That do Not Work Well and in Healthy People

Renal Impairment | Healthy Volunteers

United States
Tenaya Therapeutics
Johns Hopkins University; Mayo Clinic

Recruiting

Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC (RIDGE-1)

Arrhythmogenic Right Ventricular Cardiomyopathy

United States, Netherlands, France, United Kingdom
Stemline Therapeutics, Inc.
The Leukemia and Lymphoma Society

Completed

SL-401 in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm or Acute Myeloid Leukemia

Acute Myeloid Leukemia | Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

United States
Hippocration General Hospital

Not yet recruiting

Transcutaneous Vagal Nerve Stimulation to Prevent Tachyarrhythmias in Patients Early Following Myocardial Infarction (EARLY-VAGUS)

Myocardial Infarction | Tachyarrhythmia

Greece, United States, United Arab Emirates
Astellas Pharma Inc

Terminated

A Study to Assess the Safety, Tolerability and Preliminary Efficacy of ASP0367 (MA-0211) in Pediatric Male Participants With Duchenne Muscular Dystrophy (DMD)

Duchenne Muscular Dystrophy (DMD)

United States
Celgene

Completed

Positron Emission Tomography (PET) Imaging Study to Evaluate Enzyme Availability in the Central Nervous System Before and After CC-97489 Administration in Healthy Participants

Healthy Volunteers

Belgium
Woebot Health

Completed

Potency and Precision Investigation (PAPI)

Depression, Anxiety

United States
Arch Biopartners Inc.

Completed

A Phase I Study to Evaluate LSALT Peptide

None - Study is to Determine Safety in Healthy Participants

Australia
Fondazione Policlinico Universitario Agostino Gemelli...

Recruiting

Multiparametric Ultrasound Study in Diagnosing GvHD (ECO-STEM)

Intestinal GVHD

Italy
University of Kentucky
Inflammasome Therapeutics

Recruiting

Evaluation of Kamuvudine-8 in Subjects With Geographic Atrophy (K8 for GA)

Age-Related Macular Degeneration | Geographic Atrophy

United States
Bridge Biotherapeutics, Inc.
Covance

Terminated

Efficacy and Safety of Rectally Administered BBT-401-1S in Subjects With Ulcerative Colitis

Ulcerative Colitis

New Zealand
Weill Medical College of Cornell University

Terminated

Phase II Study of Tocilizumab for Patients With Glucocorticoid-refractory Acute GVHD After Allogeneic Hematopoetic Stem Cell Transplant (HSCT)

Glucocorticosteroid Refractory Acute GVHD

United States
Forte Biosciences, Inc.

Completed

Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

United States
Simbec Research
Sensorion

Completed

A Study of SENS 401 in Healthy Subjects

Inner Ear Disease

United Kingdom
University of Salamanca

Recruiting

Physiotherapy and Therapeutic Exercise Program in Graft-versus-host Disease (GvHD)

GVHD, Chronic | GVHD,Acute

Spain
Mayo Clinic

Recruiting

Study of Transcranial Direct Current Stimulation to Treat Epilepsy

Focal Epilepsy

United States
Astellas Pharma Europe B.V.

Completed

A Study of MA-0217 (ASP1128) in Healthy Adult Subjects and Healthy Elderly Subjects

Healthy Volunteers

United States
Coordination Pharmaceuticals, Inc.

Recruiting

Phase I Study of RiMO-401 With Radiation in Advanced Tumors

Advanced Solid Tumor | Intratumoral Injection

United States

Search clinical trials for: MA-GVHD-401

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Canada

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations